Morniflumate-induced urticaria-angioedema

Allergy: European Journal of Allergy and Clinical Immunology

Volumn 53, Issue 8, 1998, Pages 812-813

  Matheu, V ^a   Sierra, Z ^b   Gracia, M T ^b   Caloto, M ^b   Alcazar, M M ^b   Martinez, M I ^b   Zapatero, L ^b  

^a HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

^b NONE

Author keywords

Angioedema; Morniflumate; NSAID; Urticaria

Indexed keywords

MORNIFLUMATE;

ANGIONEUROTIC EDEMA; CASE REPORT; CLINICAL FEATURE; DRUG HYPERSENSITIVITY; ERYTHEMA; FEMALE; HUMAN; PRESCHOOL CHILD; PRIORITY JOURNAL; SHORT SURVEY; SKIN TEST; URTICARIA;

EID: 0031830979     PISSN: 01054538     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1398-9995.1998.tb03980.x     Document Type: Short Survey

References (6)

1. Schiantarelli P, Cadel S, Acerbi D. A gastroprotective antiinflammatory agent: the beta-morpholinoethyl ester of niflumic acid (morniflumate). Agents Actions 1984;14(2):247-56.
2. Civelli M, Vigano T, Acerbi D, et al. Modulation of arachidonic acid metabolism by orally administered morniflumate in man. Agents Actions 1991;33(3-4):233-9.
3. Manach Y, Ditisheim A. Double-blind placebo-controlled multicentre trial of the efficacy and tolerance of morniflumate suppositories in the treatment of tonsillitis in children (used with phenoxymethylpenicillin). J Int Med Res 1990;18:30-6.
4. Raymond F, Paillat A, Gambert C, Garnier P. Syndrome de Lyell après administration d'érytromycine-sulfafurazole et de morniflumate [Letter]. Arch Pediatr 1995;2:494-5.
5. de Suremain N, Le Roux P, Smith-Xiberras F, Briquet MT, Le Luyer B. Toxidermie médicamenteuse avec l'acide niflumique [Letter]. Arch Pediatr 1995;2(7):698.
6. Laguna J, Trampal A, Paz S, Santaolalla M, Mínguez A, Rodríguez M. Reacción adversa al écido niflúmico [Abstract]. Rev Esp Alergol Inmunol Clin 1997;12(2S):60.